2017
DOI: 10.1371/journal.pone.0184593
|View full text |Cite
|
Sign up to set email alerts
|

Serum copeptin and neuron specific enolase are markers of neonatal distress and long-term neurodevelopmental outcome

Abstract: The objective of this study was to evaluate the early changes in serial serum levels of copeptin and neuron-specific enolase (NSE) in neonates diagnosed with birth asphyxia, and to determine whether these biomarkers measured in the first 168 hours after birth are predictive of long-term neurodevelopmental outcome. Copeptin and NSE levels were measured from serum samples collected 6, 12, 24, 48, 72, and 168 hours after birth from 75 term neonates diagnosed with hypoxic-ischemic encephalopathy (HIE) and treated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
26
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
5
2
1

Relationship

2
6

Authors

Journals

citations
Cited by 29 publications
(29 citation statements)
references
References 29 publications
3
26
0
Order By: Relevance
“…Thus, the various actions of AVP, including the adaptive ones described in the Introduction, do not end abruptly after the asphyxic insult. Moreover, it is important to note that the post-asphyxia levels of copeptin seen in the present model are analogous to those measured in neonatal blood samples after birth (Kelen et al, 2017 ). In our previous work on copeptin as a diagnostic and prognostic biomarker of HIE, the median copeptin concentration 1 week after birth in infants diagnosed with HIE was 17.8 pmol/l (Kelen et al, 2017 ), which is still above the normal range for healthy volunteers (Struck et al, 2005 ; Morgenthaler et al, 2006 ).…”
Section: Discussionsupporting
confidence: 81%
“…Thus, the various actions of AVP, including the adaptive ones described in the Introduction, do not end abruptly after the asphyxic insult. Moreover, it is important to note that the post-asphyxia levels of copeptin seen in the present model are analogous to those measured in neonatal blood samples after birth (Kelen et al, 2017 ). In our previous work on copeptin as a diagnostic and prognostic biomarker of HIE, the median copeptin concentration 1 week after birth in infants diagnosed with HIE was 17.8 pmol/l (Kelen et al, 2017 ), which is still above the normal range for healthy volunteers (Struck et al, 2005 ; Morgenthaler et al, 2006 ).…”
Section: Discussionsupporting
confidence: 81%
“…Notably, both asphyxia protocols led to changes in blood gas parameters which fulfill the main diagnostic criteria of human BA: an acidemia with a decrease in pH below 7.0, coupled to a fall in base excess by 20 mmol/l and elevation of lactate by about 10 mmol/l. The massive release of copeptin (a stable fragment of prepro-AVP) to blood, which is triggered by the hypoxia component of asphyxia (Summanen et al, 2018), provides further support for the validity of our present model (Kelen et al, 2017;Schlapbach et al, 2011).…”
Section: Post-asphyxia Seizure Generation Depends On the Rate Of Ph Rsupporting
confidence: 72%
“…1C). In addition, the levels of plasma copeptin, a relevant biomarker of asphyxia (Kelen et al, 2017;Schlapbach et al, 2011), were highly elevated by the end of both asphyxia protocols (4.41 [1. 64 -11.15] nM and 6.32 [4.48 -7.74] nM for steady and intermittent, respectively vs. 0.22 [0.1 -2.5] nM in the control group; Fig 1D).…”
Section: Changes In Blood Ph Base Excess and Lactate And Plasma Copementioning
confidence: 99%
See 1 more Smart Citation
“…It is synthesized within 5-20 minutes after the development of acute myocardial damage and remains stable for several days [10]. There is evidence of the use of copeptin as a marker of the development of various pathological conditions in newborns [11][12][13][14], but its role in the prediction of neonatal arrhythmias in newborns together with troponin I has not been studied.…”
Section: Introductionmentioning
confidence: 99%